Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Mannose-binding lectin protein deficiency

*

* Not a rare disease

Other Names for this Disease

  • Mannose-binding protein deficiency
  • MBL deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might mannose-binding lectin protein (MBL) deficiency be treated?

Currently, there are no specific therapies available for mannose-binding lectin protein deficiency. Fresh frozen plasma may be used in emergencies to replace complement components. Routine vaccinations may be recommended (e.g., meningococcal vaccine, pneumococcal vaccine). Because a certain gene has been found to cause this condition, gene therapy may be a viable treatment in the future.[1]
Last updated: 4/9/2012

References
  1. Agrawal R. Complement deficiency. eMedicine. May 2009; http://emedicine.medscape.com/article/886128-overview. Accessed 1/9/2012.


Other Names for this Disease
  • Mannose-binding protein deficiency
  • MBL deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.